etrozole in increasing endometrial thickness in Premenopausal patient
Phase 2
- Conditions
- Endometrial hyperplasia.Endometrial glandular hyperplasia
- Registration Number
- IRCT201510244339N12
- Lead Sponsor
- Vice chancellor of research, Bushehr University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
women of reproductive age; non-pregnant; the diagnosis of endometrial hyperplasia as ultrasound and pathology.
Exclusion criteria: side effects of letrozole; the prohibition of medicine prescription.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The effect of letrozole on endometrial thickness. Timepoint: Three months and six months. Method of measurement: Transvaginal sonography.
- Secondary Outcome Measures
Name Time Method Reduction of irregular bleeding. Timepoint: Three months and six months. Method of measurement: History of the patients.